Logo image of SAR

SARATOGA INVESTMENT CORP (SAR) Stock Fundamental Analysis

NYSE:SAR - New York Stock Exchange, Inc. - US80349A2087 - Common Stock - Currency: USD

25.13  -0.33 (-1.3%)

Fundamental Rating

5

Overall SAR gets a fundamental rating of 5 out of 10. We evaluated SAR against 235 industry peers in the Capital Markets industry. SAR has an average financial health and profitability rating. SAR is valued quite cheap, while showing a decent growth score. This is a good combination! SAR also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year SAR was profitable.
In the past year SAR had a positive cash flow from operations.
SAR had positive earnings in each of the past 5 years.
In the past 5 years SAR reported 4 times negative operating cash flow.
SAR Yearly Net Income VS EBIT VS OCF VS FCFSAR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M

1.2 Ratios

SAR has a Return On Assets (2.95%) which is comparable to the rest of the industry.
With a Return On Equity value of 8.93%, SAR perfoms like the industry average, outperforming 55.32% of the companies in the same industry.
SAR has a Return On Invested Capital (3.30%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for SAR is below the industry average of 7.84%.
Industry RankSector Rank
ROA 2.95%
ROE 8.93%
ROIC 3.3%
ROA(3y)1.8%
ROA(5y)2.62%
ROE(3y)5.56%
ROE(5y)6.88%
ROIC(3y)3.34%
ROIC(5y)3%
SAR Yearly ROA, ROE, ROICSAR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

SAR has a Profit Margin of 24.85%. This is in the better half of the industry: SAR outperforms 66.81% of its industry peers.
In the last couple of years the Profit Margin of SAR has declined.
SAR has a better Operating Margin (34.62%) than 63.83% of its industry peers.
In the last couple of years the Operating Margin of SAR has grown nicely.
Looking at the Gross Margin, with a value of 41.58%, SAR is doing worse than 61.28% of the companies in the same industry.
In the last couple of years the Gross Margin of SAR has grown nicely.
Industry RankSector Rank
OM 34.62%
PM (TTM) 24.85%
GM 41.58%
OM growth 3Y8.45%
OM growth 5Y5.8%
PM growth 3Y-33.67%
PM growth 5Y-27.68%
GM growth 3Y5.15%
GM growth 5Y4.57%
SAR Yearly Profit, Operating, Gross MarginsSAR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

5

2. Health

2.1 Basic Checks

The number of shares outstanding for SAR has been increased compared to 1 year ago.
The number of shares outstanding for SAR has been increased compared to 5 years ago.
Compared to 1 year ago, SAR has an improved debt to assets ratio.
SAR Yearly Shares OutstandingSAR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
SAR Yearly Total Debt VS Total AssetsSAR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

SAR has an Altman-Z score of 0.72. This is a bad value and indicates that SAR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.72, SAR is in line with its industry, outperforming 41.70% of the companies in the same industry.
The Debt to FCF ratio of SAR is 4.46, which is a neutral value as it means it would take SAR, 4.46 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of SAR (4.46) is better than 70.64% of its industry peers.
SAR has a Debt/Equity ratio of 2.00. This is a high value indicating a heavy dependency on external financing.
SAR's Debt to Equity ratio of 2.00 is on the low side compared to the rest of the industry. SAR is outperformed by 79.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 2
Debt/FCF 4.46
Altman-Z 0.72
ROIC/WACCN/A
WACCN/A
SAR Yearly LT Debt VS Equity VS FCFSAR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 11.05 indicates that SAR has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 11.05, SAR belongs to the top of the industry, outperforming 95.74% of the companies in the same industry.
A Quick Ratio of 11.05 indicates that SAR has no problem at all paying its short term obligations.
SAR has a Quick ratio of 11.05. This is amongst the best in the industry. SAR outperforms 95.74% of its industry peers.
Industry RankSector Rank
Current Ratio 11.05
Quick Ratio 11.05
SAR Yearly Current Assets VS Current LiabilitesSAR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 104.13% over the past year.
The earnings per share for SAR have been decreasing by -18.46% on average. This is quite bad
Looking at the last year, SAR shows a decrease in Revenue. The Revenue has decreased by -3.56% in the last year.
Measured over the past years, SAR shows a very strong growth in Revenue. The Revenue has been growing by 20.56% on average per year.
EPS 1Y (TTM)104.13%
EPS 3Y-20.24%
EPS 5Y-18.46%
EPS Q2Q%89.58%
Revenue 1Y (TTM)-3.56%
Revenue growth 3Y28.14%
Revenue growth 5Y20.56%
Sales Q2Q%-6.5%

3.2 Future

Based on estimates for the next years, SAR will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.22% on average per year.
Based on estimates for the next years, SAR will show a decrease in Revenue. The Revenue will decrease by -6.96% on average per year.
EPS Next Y36.71%
EPS Next 2Y14.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-14.5%
Revenue Next 2Y-6.96%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SAR Yearly Revenue VS EstimatesSAR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
SAR Yearly EPS VS EstimatesSAR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.17 indicates a reasonable valuation of SAR.
Based on the Price/Earnings ratio, SAR is valued a bit cheaper than the industry average as 75.32% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of SAR to the average of the S&P500 Index (27.54), we can say SAR is valued rather cheaply.
A Price/Forward Earnings ratio of 9.44 indicates a reasonable valuation of SAR.
Based on the Price/Forward Earnings ratio, SAR is valued cheaper than 80.85% of the companies in the same industry.
SAR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.44.
Industry RankSector Rank
PE 10.17
Fwd PE 9.44
SAR Price Earnings VS Forward Price EarningsSAR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of SAR indicates a rather cheap valuation: SAR is cheaper than 91.91% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.22
EV/EBITDA N/A
SAR Per share dataSAR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

SAR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SAR's earnings are expected to grow with 14.22% in the coming years.
PEG (NY)0.28
PEG (5Y)N/A
EPS Next 2Y14.22%
EPS Next 3YN/A

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 12.48%, SAR is a good candidate for dividend investing.
SAR's Dividend Yield is rather good when compared to the industry average which is at 8.00. SAR pays more dividend than 80.43% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.35, SAR pays a better dividend.
Industry RankSector Rank
Dividend Yield 12.48%

5.2 History

On average, the dividend of SAR grows each year by 9.46%, which is quite nice.
SAR has paid a dividend for at least 10 years, which is a reliable track record.
SAR has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)9.46%
Div Incr Years4
Div Non Decr Years4
SAR Yearly Dividends per shareSAR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

136.79% of the earnings are spent on dividend by SAR. This is not a sustainable payout ratio.
SAR's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP136.79%
EPS Next 2Y14.22%
EPS Next 3YN/A
SAR Yearly Income VS Free CF VS DividendSAR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M
SAR Dividend Payout.SAR Dividend Payout, showing the Payout Ratio.SAR Dividend Payout.PayoutRetained Earnings

SARATOGA INVESTMENT CORP

NYSE:SAR (7/18/2025, 8:11:04 PM)

25.13

-0.33 (-1.3%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)07-08 2025-07-08/amc
Earnings (Next)10-06 2025-10-06/amc
Inst Owners17.49%
Inst Owner Change1.21%
Ins Owners10.94%
Ins Owner Change0%
Market Cap393.79M
Analysts73.33
Price Target25.03 (-0.4%)
Short Float %1.88%
Short Ratio1.99
Dividend
Industry RankSector Rank
Dividend Yield 12.48%
Yearly Dividend2.83
Dividend Growth(5Y)9.46%
DP136.79%
Div Incr Years4
Div Non Decr Years4
Ex-Date09-04 2025-09-04 (0.25)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-54.95%
Min EPS beat(2)-107.09%
Max EPS beat(2)-2.81%
EPS beat(4)1
Avg EPS beat(4)-35.17%
Min EPS beat(4)-107.09%
Max EPS beat(4)1.95%
EPS beat(8)1
Avg EPS beat(8)-52.46%
EPS beat(12)2
Avg EPS beat(12)-42.59%
EPS beat(16)5
Avg EPS beat(16)-32.94%
Revenue beat(2)1
Avg Revenue beat(2)2.08%
Min Revenue beat(2)-6.72%
Max Revenue beat(2)10.88%
Revenue beat(4)2
Avg Revenue beat(4)2.46%
Min Revenue beat(4)-9%
Max Revenue beat(4)14.69%
Revenue beat(8)3
Avg Revenue beat(8)-0.6%
Revenue beat(12)7
Avg Revenue beat(12)3.39%
Revenue beat(16)9
Avg Revenue beat(16)2.76%
PT rev (1m)-2.32%
PT rev (3m)-3.99%
EPS NQ rev (1m)-4.01%
EPS NQ rev (3m)-8.21%
EPS NY rev (1m)-7.75%
EPS NY rev (3m)-6.73%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-2.92%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)-3.62%
Valuation
Industry RankSector Rank
PE 10.17
Fwd PE 9.44
P/S 2.76
P/FCF 2.22
P/OCF 2.22
P/B 0.99
P/tB 0.99
EV/EBITDA N/A
EPS(TTM)2.47
EY9.83%
EPS(NY)2.66
Fwd EY10.59%
FCF(TTM)11.34
FCFY45.12%
OCF(TTM)11.34
OCFY45.12%
SpS9.09
BVpS25.29
TBVpS25.29
PEG (NY)0.28
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.95%
ROE 8.93%
ROCE 4.17%
ROIC 3.3%
ROICexc 4.07%
ROICexgc 4.08%
OM 34.62%
PM (TTM) 24.85%
GM 41.58%
FCFM 124.7%
ROA(3y)1.8%
ROA(5y)2.62%
ROE(3y)5.56%
ROE(5y)6.88%
ROIC(3y)3.34%
ROIC(5y)3%
ROICexc(3y)3.72%
ROICexc(5y)3.29%
ROICexgc(3y)3.72%
ROICexgc(5y)3.29%
ROCE(3y)4.22%
ROCE(5y)3.8%
ROICexcg growth 3Y30.31%
ROICexcg growth 5Y10.28%
ROICexc growth 3Y30.28%
ROICexc growth 5Y10.29%
OM growth 3Y8.45%
OM growth 5Y5.8%
PM growth 3Y-33.67%
PM growth 5Y-27.68%
GM growth 3Y5.15%
GM growth 5Y4.57%
F-Score6
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 2
Debt/FCF 4.46
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.05
Cash Conversion N/A
Profit Quality 501.82%
Current Ratio 11.05
Quick Ratio 11.05
Altman-Z 0.72
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)104.13%
EPS 3Y-20.24%
EPS 5Y-18.46%
EPS Q2Q%89.58%
EPS Next Y36.71%
EPS Next 2Y14.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.56%
Revenue growth 3Y28.14%
Revenue growth 5Y20.56%
Sales Q2Q%-6.5%
Revenue Next Year-14.5%
Revenue Next 2Y-6.96%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-10.67%
EBIT growth 3Y38.97%
EBIT growth 5Y27.55%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y210.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y210.32%
OCF growth 3YN/A
OCF growth 5YN/A